首页> 外文期刊>Disease models & mechanisms: DMM >Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model
【24h】

Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model

机译:极化上皮细胞模型中的突变Bestrophin-1表达,定位和功能的恢复

获取原文
       

摘要

Autosomal recessive bestrophinopathy (ARB) is a retinopathy caused by mutations in the bestrophin-1 protein, which is thought to function as a Ca2+-gated Cl? channel in the basolateral surface of the retinal pigment epithelium (RPE). Using a stably transfected polarised epithelial cell model, we show that four ARB mutant bestrophin-1 proteins were mislocalised and subjected to proteasomal degradation. In contrast to the wild-type bestrophin-1, each of the four mutant proteins also failed to conduct Cl? ions in transiently transfected cells as determined by whole-cell patch clamp. We demonstrate that a combination of two clinically approved drugs, bortezomib and 4-phenylbutyrate (4PBA), successfully restored the expression and localisation of all four ARB mutant bestrophin-1 proteins. Importantly, the Cl? conductance function of each of the mutant bestrophin-1 proteins was fully restored to that of wild-type bestrophin-1 by treatment of cells with 4PBA alone. The functional rescue achieved with 4PBA is significant because it suggests that this drug, which is already approved for long-term use in infants and adults, might represent a promising therapy for the treatment of ARB and other bestrophinopathies resulting from missense mutations in BEST1.
机译:常染色体隐性性骨质疏松症(ARB)是一种由bestrophin-1蛋白突变引起的视网膜病,据认为该蛋白在大鼠中起着Ca 2 + 门控的Cl ?通道的作用。视网膜色素上皮(RPE)的基底外侧表面。使用稳定转染的极化上皮细胞模型,我们显示了四个ARB突变体Bestrophin-1蛋白错位并受到蛋白酶体降解。与野生型Bestrophin-1不同,通过全细胞膜片钳检测,这四个突变蛋白中的每一个在瞬时转染的细胞中也都不能传导Cl ?离子。我们证明两种临床批准的药物,硼替佐米和4-苯基丁酸酯(4PBA)的组合,成功地恢复了所有四个ARB突变体bestrophin-1蛋白的表达和定位。重要的是,通过仅用4PBA处理细胞,每种突变的Bestrophin-1蛋白的Cl ?电导功能已完全恢复为野生型Bestrophin-1。用4PBA实现的功能抢救意义重大,因为这表明该药物已经被批准可在婴儿和成人中长期使用,可能代表了一种有前途的疗法,可用于治疗因BEST1错义突变而引起的ARB和其他雌激素病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号